GlassScriptPhysician profile
Heather Romano
NPI 1922623198
$3,337.78
in general payments reported to CMS, 2019-2025
28 companies · $2,059 in 2025
The $2,059 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2022: $409 · 2023: $114 · 2024: $643 · 2025: $2,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863 · Travel and Lodging: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.30 |
| Travel and Lodging | $951.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,360.24 | 2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $264.15 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $205.39 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $171.73 | 2024 | Optimizer |
| Corcept Therapeutics | $170.14 | 2024-2025 | Korlym |
| Novo Nordisk INC | $163.72 | 2021-2025 | Ozempic, Rybelsus |
| Beta Bionics, INC. | $157.45 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sequel Med Tech, LLC | $150.73 | 2025 | Twiist |
| Alexion Pharmaceuticals, INC. | $84.33 | 2022-2024 | Ultomiris |
| Amgen INC. | $82.75 | 2022-2025 | Evenity, Prolia |
| Insulet Corporation | $76.12 | 2022-2023 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $66.89 | 2025 | Eohilia, Hyqvia |
| Lilly USA, LLC | $65.01 | 2022-2023 | Mounjaro |
| Boston Scientific Corporation | $43.03 | 2025 | Wavewriter Alpha Prime 16 |
| Sanofi-Aventis U.S. LLC | $34.29 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $33.51 | 2024-2025 | Zenpep |
| Dexcom, INC. | $30.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.00 | 2025 | |
| Recordati_rare_diseases_inc. | $22.76 | 2024 | Signifor Lar, Isturisa |
| Madrigal Pharmaceuticals | $19.89 | 2025 | Rezdiffra |
| Xeris Pharmaceuticals, INC. | $18.39 | 2022 | |
| Braintree Laboratories, INC. | $15.16 | 2025 | Suflave, Sutab |
| Exact Sciences Corporation | $14.60 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $13.91 | 2025 | Wainua |
| Tg Therapeutics, INC. | $13.21 | 2024 | |
| Lundbeck LLC | $13.21 | 2024 | Vyepti |
| Merck Sharp & Dohme LLC | $11.70 | 2022 | |
| Phathom Pharmaceuticals, INC. | $10.61 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Romano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.